APA (7th ed.) Citation

Park, K., Shin, I., Shin, I., Kim, Y., Kang, H., Oh, S., . . . Lee, M. (2024). A novel NLRP3 inhibitor as a therapeutic agent against monosodium urate-induced gout. Frontiers Media S.A.

Chicago Style (17th ed.) Citation

Park, Kihyoun, et al. A Novel NLRP3 Inhibitor as a Therapeutic Agent Against Monosodium Urate-induced Gout. Frontiers Media S.A, 2024.

MLA (9th ed.) Citation

Park, Kihyoun, et al. A Novel NLRP3 Inhibitor as a Therapeutic Agent Against Monosodium Urate-induced Gout. Frontiers Media S.A, 2024.

Warning: These citations may not always be 100% accurate.